APP and Alzheimer disease: Supporting the involvement of SP1 in the molecular mechanisms underlying Aβ-induced toxicity in AD, a significant increase in both SP1 messenger and protein levels was found in the cortex of AD patients and in two mouse models of AD, APP/PS1 mice and Tg2576 mice (Citron et al., 2008).